• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝内胆管癌根治性切除术后的预后列线图。

Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy.

机构信息

Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, 200438, P.R. China.

出版信息

J Clin Oncol. 2013 Mar 20;31(9):1188-95. doi: 10.1200/JCO.2012.41.5984. Epub 2013 Jan 28.

DOI:10.1200/JCO.2012.41.5984
PMID:23358969
Abstract

PURPOSE

This study aimed to establish an effective prognostic nomogram for intrahepatic cholangiocarcinoma (ICC) after partial hepatectomy.

PATIENTS AND METHODS

The nomogram was based on a retrospectively study on 367 patients who underwent partial hepatectomy for ICC at the Eastern Hepatobiliary Surgery Hospital from 2002 to 2007. The predictive accuracy and discriminative ability of the nomogram were determined by concordance index (C-index) and calibration curve and compared with five currently used staging systems on ICC. The results were validated using bootstrap resampling and a prospective study on 82 patients operated on from 2007 to 2008 at the same institution.

RESULTS

On multivariate analysis of the primary cohort, independent factors for survival were serum carcinoembryonic antigen, CA 19-9, tumor diameter and number, vascular invasion, lymph node metastasis, direct invasion, and local extrahepatic metastasis, which were all selected into the nomogram. The calibration curve for probability of survival showed good agreement between prediction by nomogram and actual observation. The C-index of the nomogram for predicting survival was 0.74 (95% CI, 0.71 to 0.77), which was statistically higher than the C-index values of the following systems: American Joint Committee on Cancer (AJCC) seventh edition (0.65), AJCC sixth edition (0.65), Nathan (0.64), Liver Cancer Study Group of Japan (0.64), and Okabayashi (0.67; P < .001 for all). It was also higher (0.74) in predicting survival for the mass-forming type of ICC (P < .001). In the validation cohort, the nomogram discrimination was superior to the five other staging systems (C-index: 0.75 v 0.60 to 0.63; P < .001 for all).

CONCLUSION

The proposed nomogram resulted in more-accurate prognostic prediction for patients with ICC after partial hepatectomy.

摘要

目的

本研究旨在为接受肝部分切除术的肝内胆管细胞癌(ICC)患者建立一种有效的预后列线图。

方法

该列线图基于 2002 年至 2007 年在东方肝胆外科医院接受肝部分切除术治疗 ICC 的 367 例患者的回顾性研究。通过一致性指数(C 指数)和校准曲线来确定列线图的预测准确性和判别能力,并与目前用于 ICC 的五种分期系统进行比较。通过 bootstrap 重采样和对同一机构 2007 年至 2008 年接受手术的 82 例患者的前瞻性研究对结果进行验证。

结果

在原发性队列的多变量分析中,独立的生存因素为血清癌胚抗原、CA 19-9、肿瘤直径和数量、血管侵犯、淋巴结转移、直接侵犯和局部肝外转移,这些因素均被纳入列线图。生存概率的校准曲线显示,列线图预测与实际观察之间具有良好的一致性。预测生存的列线图的 C 指数为 0.74(95%CI,0.71 至 0.77),统计学上高于以下系统的 C 指数值:美国癌症联合委员会(AJCC)第七版(0.65)、AJCC 第六版(0.65)、Nathan(0.64)、日本肝癌研究组(0.64)和 Okabayashi(0.67;所有 P 值均<.001)。在预测肿块形成型 ICC 的生存方面,它也更高(0.74;P<.001)。在验证队列中,该列线图的判别能力优于其他五种分期系统(C 指数:0.75 比 0.60 至 0.63;所有 P 值均<.001)。

结论

提出的列线图可更准确地预测接受肝部分切除术的 ICC 患者的预后。

相似文献

1
Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy.肝内胆管癌根治性切除术后的预后列线图。
J Clin Oncol. 2013 Mar 20;31(9):1188-95. doi: 10.1200/JCO.2012.41.5984. Epub 2013 Jan 28.
2
A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience.列线图预测肝内胆管细胞癌切除术后的长期生存:东西方经验。
JAMA Surg. 2014 May;149(5):432-8. doi: 10.1001/jamasurg.2013.5168.
3
A Prognostic Nomogram for Overall Survival of Patients After Hepatectomy for Intrahepatic Cholangiocarcinoma.肝内胆管癌肝切除术后患者总生存的预后列线图
Anticancer Res. 2016 Aug;36(8):4249-58.
4
Risk stratification system to predict recurrence of intrahepatic cholangiocarcinoma after hepatic resection.预测肝切除术后肝内胆管癌复发的风险分层系统。
BMC Cancer. 2017 Jul 3;17(1):464. doi: 10.1186/s12885-017-3464-5.
5
Clinicopathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocarcinoma: relevance of the lymphatic invasion index.大细胞型肝内胆管细胞癌患者肝切除术后的临床病理预后因素:淋巴血管侵犯指数的相关性。
Ann Surg Oncol. 2010 Jul;17(7):1816-22. doi: 10.1245/s10434-010-0929-z. Epub 2010 Feb 5.
6
Adjuvant Transarterial Chemoembolization Following Liver Resection for Intrahepatic Cholangiocarcinoma Based on Survival Risk Stratification.基于生存风险分层的肝内胆管癌肝切除术后辅助经动脉化疗栓塞术
Oncologist. 2015 Jun;20(6):640-7. doi: 10.1634/theoncologist.2014-0470. Epub 2015 May 8.
7
Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis.肝切除术后肝内胆管癌的预后因素:单因素和多因素分析
Hepatogastroenterology. 2002 Mar-Apr;49(44):311-6.
8
Retrospective analysis of histopathologic prognostic factors after hepatectomy for intrahepatic cholangiocarcinoma.肝内胆管癌肝切除术后组织病理学预后因素的回顾性分析
Cancer J. 2009 May-Jun;15(3):257-61. doi: 10.1097/PPO.0b013e31819e3312.
9
Serosal invasion in TNM staging of mass-forming intrahepatic cholangiocarcinoma.肿块型肝内胆管癌TNM分期中的浆膜侵犯
J Hepatobiliary Pancreat Surg. 2005;12(6):479-83. doi: 10.1007/s00534-005-1026-8.
10
A nomogram to predict lymph node metastasis before resection in intrahepatic cholangiocarcinoma.一种用于预测肝内胆管癌切除术前淋巴结转移的列线图。
J Surg Res. 2018 Jun;226:56-63. doi: 10.1016/j.jss.2018.01.024. Epub 2018 Feb 10.

引用本文的文献

1
Development and validation of a nomogram for predicting overall survival in patients with primary central nervous system germ cell tumors.原发性中枢神经系统生殖细胞肿瘤患者总生存预测列线图的开发与验证
Front Immunol. 2025 Aug 20;16:1630061. doi: 10.3389/fimmu.2025.1630061. eCollection 2025.
2
A TARGET database-driven nomogram for pediatric osteosarcoma prognosis.一种用于小儿骨肉瘤预后的TARGET数据库驱动的列线图。
Discov Oncol. 2025 Aug 20;16(1):1586. doi: 10.1007/s12672-025-03359-5.
3
Transarterial Chemoembolization Following Curative Resection May Not Improve Survival for Hepatitis B Virus Associated Intrahepatic Cholangiocarcinoma: Propensity Score Weighting Analysis.
根治性切除术后经动脉化疗栓塞术可能无法改善乙型肝炎病毒相关性肝内胆管癌的生存率:倾向评分加权分析
J Hepatocell Carcinoma. 2025 Aug 12;12:1781-1793. doi: 10.2147/JHC.S518418. eCollection 2025.
4
Real-World Single-Center Experience with Neoadjuvant Gemcitabine, Cisplatin, and Durvalumab in Borderline Resectable Cholangiocarcinoma.吉西他滨、顺铂和度伐利尤单抗新辅助治疗可切除边缘胆管癌的单中心真实世界经验
Ann Surg Oncol. 2025 Aug 13. doi: 10.1245/s10434-025-18046-6.
5
Five-year survival of patients with hilar cholangiocarcinoma: a single-center retrospective study.肝门部胆管癌患者的5年生存率:一项单中心回顾性研究
Ann Surg Treat Res. 2025 Aug;109(2):71-80. doi: 10.4174/astr.2025.109.2.71. Epub 2025 Jul 30.
6
Preoperative Prediction of Microvascular Invasion in Intrahepatic Cholangiocarcinoma and Its Prognostic Implications: A Multicenter Study.肝内胆管癌微血管侵犯的术前预测及其预后意义:一项多中心研究
Liver Cancer. 2025 Jun 24. doi: 10.1159/000547071.
7
A Scoring System for Risk Stratification in Intrahepatic Cholangiocarcinoma after Immunotherapy.免疫治疗后肝内胆管癌风险分层的评分系统
Radiol Imaging Cancer. 2025 Jul;7(4):e240430. doi: 10.1148/rycan.240430.
8
Identifying risk factors of biliary tract cancers using a large Japanese regional insurance claims database.利用一个大型日本地区保险理赔数据库确定胆道癌的风险因素。
Sci Rep. 2025 Jul 8;15(1):24347. doi: 10.1038/s41598-025-09790-6.
9
Nomogram based on the advanced lung cancer inflammation index and other relevant clinical factors for patients with cervical squamous cell carcinoma undergoing concurrent chemoradiotherapy.基于晚期肺癌炎症指数及其他相关临床因素的列线图,用于接受同步放化疗的宫颈鳞状细胞癌患者。
BMC Cancer. 2025 Jul 1;25(1):1043. doi: 10.1186/s12885-025-14465-6.
10
Who benefits from adjuvant chemotherapy? Identification of early recurrence in intrahepatic cholangiocarcinoma patients after curative-intent resection using machine learning algorithms.谁能从辅助化疗中获益?使用机器学习算法识别肝内胆管癌患者根治性切除术后的早期复发情况。
Front Oncol. 2025 Jun 6;15:1594200. doi: 10.3389/fonc.2025.1594200. eCollection 2025.